WO2007052308A3 - Glyco-phosphorylated biologically active agents - Google Patents

Glyco-phosphorylated biologically active agents Download PDF

Info

Publication number
WO2007052308A3
WO2007052308A3 PCT/IN2006/000434 IN2006000434W WO2007052308A3 WO 2007052308 A3 WO2007052308 A3 WO 2007052308A3 IN 2006000434 W IN2006000434 W IN 2006000434W WO 2007052308 A3 WO2007052308 A3 WO 2007052308A3
Authority
WO
WIPO (PCT)
Prior art keywords
biologically active
glyco
phosphorylated
active agents
radical
Prior art date
Application number
PCT/IN2006/000434
Other languages
French (fr)
Other versions
WO2007052308A2 (en
Inventor
Ramanathan Halasya
Original Assignee
Brain N' Beyond Biotech Pvt. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brain N' Beyond Biotech Pvt. Ltd. filed Critical Brain N' Beyond Biotech Pvt. Ltd.
Publication of WO2007052308A2 publication Critical patent/WO2007052308A2/en
Publication of WO2007052308A3 publication Critical patent/WO2007052308A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a compound of formula I: (I) wherein DX is a radical of a biologically active agent comprising atom X; X is selected from O and N; and A is a radical of a saccharide, or an acid, salt, or ester thereof. Further, the invention relates to a pharmaceutical composition comprising compound of formula I, a process of preparing the same and method of management of tumor, inflammation, infection and promoting passage across blood-brain barrier.
PCT/IN2006/000434 2005-11-03 2006-11-01 Glyco-phosphorylated biologically active agents WO2007052308A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1609CH2005 2005-11-03
IN1609/CHE/2005 2005-11-03

Publications (2)

Publication Number Publication Date
WO2007052308A2 WO2007052308A2 (en) 2007-05-10
WO2007052308A3 true WO2007052308A3 (en) 2009-10-15

Family

ID=38006316

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2006/000434 WO2007052308A2 (en) 2005-11-03 2006-11-01 Glyco-phosphorylated biologically active agents

Country Status (1)

Country Link
WO (1) WO2007052308A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007060692A2 (en) * 2005-11-24 2007-05-31 Brain N' Beyond Biotech Pvt. Ltd. Compositions for increasing bioavailability of peptides or proteins and method thereof
TWI630208B (en) 2008-12-08 2018-07-21 歐陸斯迪公司 Dihydroetorphine
BR112013020864A2 (en) 2011-02-18 2019-09-24 Alexion Pharma Int Sarl methods for synthesizing molybdopterin z-precursor derivatives
BR112014001959A2 (en) * 2011-07-27 2017-02-21 Hunan Fangshenghuamei Medical Tech Co Ltd water-soluble camptothencin derivative, pharmaceutical composition and application thereof
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
CN110845559B (en) * 2018-08-21 2023-02-28 四川福生源科技有限公司 Novel camptothecin derivative and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318594A1 (en) * 1983-01-18 1984-11-22 Hoechst Ag, 6230 Frankfurt MOENOMYCIN A DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AN ANTIBIOTICS
WO1997002046A2 (en) * 1995-07-05 1997-01-23 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Saccharide conjugates

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318594A1 (en) * 1983-01-18 1984-11-22 Hoechst Ag, 6230 Frankfurt MOENOMYCIN A DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AN ANTIBIOTICS
WO1997002046A2 (en) * 1995-07-05 1997-01-23 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Saccharide conjugates

Also Published As

Publication number Publication date
WO2007052308A2 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
RU2009126767A (en) 1-Phenyl-1-thio-d-glucitol derivative
WO2010136474A3 (en) Substituted aminobutyric derivatives as neprilysin inhibitors
WO2009063202A3 (en) Use of crth2 antagonist compounds
WO2008057802A3 (en) Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
WO2004037789A8 (en) Methylene urea derivatives as raf-kinase inhibitors
UA97351C2 (en) Coumarin derivative having antitumor activity
HK1091481A1 (en) Therapeutic agents useful for treating pain
WO2007052308A3 (en) Glyco-phosphorylated biologically active agents
WO2005056524A3 (en) Therapeutic agents useful for treating pain
WO2005030766A8 (en) Phenyl - carboxamide compounds useful for treating pain
NO20050573L (en) 4-'7-halo-2-quino (XA) linyloxy phenoxypropionic acid derivatives as antineoplastic agents
WO2006081431A3 (en) Compounds for treating inflammatory and demyelinating diseases
NO20076425L (en) Methods of Treating Drug-Resistant Cancer
SI1970372T1 (en) Salts of 9-oxoacridine-10-acetic acid with 1-alkylamno-1-desoxy-polyols
BR0311136A (en) compound or a pharmaceutically acceptable salt, enanciomer, diastereomer or ester in vivo or mixture thereof, composition, and method for inhibiting the lethal factor (lf) activity released from bacteria in a mammal
NO20076396L (en) Substituted acrylamide derivative and pharmaceutical composition comprising this
MX2009011818A (en) N-halogenated amino acid formulations with anti-inflammatory compounds.
ATE308540T1 (en) ANTITHROMBOTIC AGENTS
WO2002064552A8 (en) 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
TW200740428A (en) Substituted propanamide derivatives and pharmaceutical compositions thereof
WO2003053337A3 (en) Therapeutic compositions
DE602005017629D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEISHMANIASIS
SE9903611D0 (en) Novel compounds III
WO2002055022A3 (en) Active metabolite of antifungal compound
WO2007042983A3 (en) Fluridone as an anti-inflammatory agent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06832293

Country of ref document: EP

Kind code of ref document: A2